Last 7 days
-3.3%
Last 30 days
-12.9%
Last 90 days
-23.1%
Trailing 12 Months
-20.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 440.9B | 324.2B | -6.04% | -5.61% | 21.91 | 1.36 | 12.71% | 16.40% |
CI | 91.1B | 180.5B | -9.45% | 16.50% | 13.64 | 1.92 | 3.70% | 24.58% |
HUM | 62.6B | 92.9B | -3.60% | 10.39% | 22.31 | 0.67 | 11.81% | -4.33% |
CNC | 34.8B | 144.5B | -13.05% | -25.78% | 28.95 | 0.24 | 14.74% | -10.76% |
MID-CAP | ||||||||
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
HQY | 5.0B | 831.2M | -11.67% | 3.11% | -84.99 | 6.01 | 12.11% | -862.52% |
AMN | 3.6B | 5.2B | -10.88% | -15.90% | 8.03 | 0.68 | 31.60% | 35.63% |
CRVL | 3.2B | 704.5M | -0.70% | 13.53% | 47.24 | 4.55 | 13.56% | 10.15% |
PDCO | 2.5B | 6.4B | -14.06% | -14.67% | 12.88 | 0.39 | -0.52% | 17.01% |
SMALL-CAP | ||||||||
TVTY | 1.6B | - | 0.59% | 17.88% | 18.77 | 3.24 | - | - |
ADUS | 1.6B | 951.1M | -7.28% | 30.41% | 34.53 | 1.67 | 10.02% | 1.99% |
RDNT | 1.3B | 1.4B | 12.22% | 10.36% | 120.12 | 0.89 | 8.74% | -56.93% |
BKD | 524.3M | 2.8B | -3.12% | -59.80% | -2.2 | 0.19 | 2.43% | -140.13% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 2.6% | 31,974 | 31,160 | 30,273 | 29,019 | 27,771 |
S&GA Expenses | 2.2% | 2,311 | 2,261 | 2,233 | 2,166 | 2,068 |
Costs and Expenses | 3.0% | 30,801 | 29,901 | 29,128 | 27,962 | 26,751 |
EBITDA | -3.5% | 1,349 | 1,398 | 1,271 | 1,170 | - |
EBITDA Margin | -6.0% | 0.04* | 0.04* | 0.04* | 0.04* | - |
Earnings Before Taxes | -5.2% | 1,063 | 1,121 | 1,005 | 914 | 875 |
EBT Margin | -7.6% | 0.03* | 0.04* | 0.03* | 0.03* | - |
Interest Expenses | -2.7% | 110 | 113 | 115 | 118 | 120 |
Net Income | -5.6% | 792 | 839 | 752 | 689 | 659 |
Net Income Margin | -8.0% | 0.02* | 0.03* | 0.02* | 0.02* | - |
Free Cahsflow | -53.9% | 682 | 1,480 | 1,691 | 1,830 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -3.7% | 12,314 | 12,793 | 12,572 | 12,360 | 12,209 |
Current Assets | -3.9% | 10,084 | 10,492 | 10,332 | 10,146 | 10,064 |
Cash Equivalents | -5.6% | 4,006 | 4,242 | 4,312 | 4,804 | 4,438 |
Liabilities | -4.1% | 9,350 | 9,752 | 9,742 | 9,566 | 9,579 |
Current Liabilities | -5.3% | 6,855 | 7,242 | 7,225 | 7,041 | 7,047 |
LT Debt, Non Current | 0.0% | 2,176 | 2,175 | 2,175 | 2,174 | 2,173 |
Shareholder's Equity | -2.5% | 2,964 | 3,041 | 2,830 | 2,794 | 2,630 |
Retained Earnings | -4.8% | 2,796 | 2,937 | 2,707 | 2,657 | 2,399 |
Additional Paid-In Capital | 13.5% | 328 | 289 | 251 | 218 | 236 |
Accumulated Depreciation | - | 632 | - | - | - | - |
Shares Outstanding | 0% | 58.00 | 58.00 | 58.00 | 59.00 | 58.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -51.1% | 773 | 1,582 | 1,789 | 1,914 | 2,119 |
Share Based Compensation | 0% | 103 | 103 | 94.00 | 82.00 | 72.00 |
Cashflow From Investing | 46.8% | -790 | -1,485 | -1,836 | -1,492 | -1,653 |
Cashflow From Financing | -86.1% | -441 | -237 | -251 | -53.00 | -183 |
Buy Backs | 100.0% | 400 | 200 | 200 | 6.00 | 128 |
74.6%
13.8%
0%
Y-axis is the maximum loss one would have experienced if Molina Healthcare was unfortunately bought at previous high price.
23.0%
22.0%
27.7%
21.2%
FIve years rolling returns for Molina Healthcare.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -1.31 | -4,939 | 347,061 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -7.99 | -21,715,200 | 253,771,000 | 0.28% |
2023-03-08 | SHEETS SMITH WEALTH MANAGEMENT | unchanged | - | 834 | 335,834 | 0.05% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -19.99 | -653,000 | 2,623,000 | 0.01% |
2023-02-28 | Voya Investment Management LLC | reduced | -15.71 | -2,614,580 | 14,133,400 | 0.02% |
2023-02-27 | ST GERMAIN D J CO INC | new | - | 36,324 | 36,324 | 0.01% |
2023-02-24 | NATIXIS | added | 100 | 7,589,810 | 15,151,800 | 0.09% |
2023-02-24 | National Pension Service | reduced | -1.73 | -629,874 | 30,982,600 | 0.06% |
2023-02-24 | SRS Capital Advisors, Inc. | reduced | -25.00 | -9.00 | 991 | -% |
2023-02-23 | Chesapeake Wealth Management | reduced | -59.98 | -518,600 | 346,400 | 0.15% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 4.1% | 2,374,111 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 7.2% | 4,197,757 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 11.32% | 6,613,211 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 3.17% | 1,853,625 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.4% | 4,919,391 | SC 13G/A | |
Apr 08, 2022 | vanguard group inc | 10.99% | 6,449,375 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 7.0% | 4,061,719 | SC 13G/A | |
Feb 11, 2022 | capital world investors | 9.1% | 5,339,026 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 5.08% | 2,968,697 | SC 13G |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 182.22 -30.92% | 270.58 2.58% | 472.96 79.30% | 772.27 192.77% | 943.28 257.60% |
Current Inflation | 168.88 -35.98% | 245.29 -7.01% | 418.36 58.60% | 671.82 154.69% | 814.31 208.71% |
Very High Inflation | 152.24 -42.29% | 214.67 -18.62% | 354.04 34.22% | 555.41 110.56% | 666.09 152.52% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 06, 2023 | 8-K | Current Report | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading | |
Feb 14, 2023 | SC 13G/A | Major Ownership Report | |
Feb 13, 2023 | 10-K | Annual Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | COOPERMAN DANIEL | sold | -1,383,830 | 276 | -5,000 | - |
2023-03-03 | COOPERMAN DANIEL | acquired | 165,100 | 33.02 | 5,000 | - |
2023-03-01 | WOYS JAMES | acquired | 6,762,040 | 273 | 24,697 | evp, health plan services |
2023-03-01 | Keim Mark Lowell | sold (taxes) | -3,751,200 | 273 | -13,708 | chief financial officer |
2023-03-01 | Keim Mark Lowell | acquired | 8,280,880 | 273 | 30,324 | chief financial officer |
2023-03-01 | WOYS JAMES | sold (taxes) | -2,506,090 | 273 | -9,153 | evp, health plan services |
2023-03-01 | Russo Marc | sold (taxes) | -5,689,560 | 273 | -20,780 | evp, health plans |
2023-03-01 | HEBERT MAURICE | sold (taxes) | -378,392 | 273 | -1,382 | chief accounting officer |
2023-03-01 | Zubretsky Joseph M | sold (taxes) | -21,444,800 | 273 | -78,323 | president & ceo |
2023-03-01 | Russo Marc | acquired | 12,885,600 | 273 | 47,062 | evp, health plans |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Revenue: | ||||
Premium revenue | $ 7,636 | $ 6,800 | $ 22,966 | $ 19,689 |
Premium tax revenue | 223 | 204 | 646 | 576 |
Investment income | 49 | 20 | 82 | 39 |
Other revenue | 19 | 16 | 57 | 58 |
Total revenue | 7,927 | 7,040 | 23,751 | 20,362 |
Operating expenses: | ||||
Medical care costs | 6,748 | 6,049 | 20,183 | 17,342 |
General and administrative expenses | 560 | 532 | 1,682 | 1,489 |
Premium tax expenses | 223 | 204 | 646 | 576 |
Depreciation and amortization | 45 | 32 | 129 | 96 |
Other | 16 | 2 | 43 | 30 |
Total operating expenses | 7,592 | 6,819 | 22,683 | 19,533 |
Operating income | 335 | 221 | 1,068 | 829 |
Other expenses, net: | ||||
Interest expense | 28 | 30 | 83 | 90 |
Total other expenses, net | 28 | 30 | 83 | 90 |
Income before income tax expense | 307 | 191 | 985 | 739 |
Income tax expense | 77 | 48 | 249 | 183 |
Net income | $ 230 | $ 143 | $ 736 | $ 556 |
Net income per share: | ||||
Net income per share - Basic (in dollars per share) | $ 4.00 | $ 2.49 | $ 12.74 | $ 9.63 |
Net income per share - Diluted (in dollars per share) | $ 3.95 | $ 2.46 | $ 12.58 | $ 9.51 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 4,242 | $ 4,438 |
Investments | 3,639 | 3,202 |
Receivables | 2,220 | 2,177 |
Prepaid expenses and other current assets | 391 | 247 |
Total current assets | 10,492 | 10,064 |
Property, equipment, and capitalized software, net | 412 | 396 |
Goodwill, and intangible assets, net | 1,263 | 1,252 |
Restricted investments | 242 | 212 |
Deferred income taxes | 198 | 106 |
Other assets | 186 | 179 |
Total assets | 12,793 | 12,209 |
Current liabilities: | ||
Medical claims and benefits payable | 3,622 | 3,363 |
Amounts due government agencies | 2,139 | 2,472 |
Accounts payable, accrued liabilities and other | 818 | 842 |
Deferred revenue | 663 | 370 |
Total current liabilities | 7,242 | 7,047 |
Long-term debt | 2,175 | 2,173 |
Finance lease liabilities | 217 | 219 |
Other long-term liabilities | 118 | 140 |
Total liabilities | 9,752 | 9,579 |
Stockholders’ equity: | ||
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at September 30, 2022 and December 31, 2021 | 0 | 0 |
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding | 0 | 0 |
Additional paid-in capital | 289 | 236 |
Accumulated other comprehensive loss | (185) | (5) |
Retained earnings | 2,937 | 2,399 |
Total stockholders’ equity | 3,041 | 2,630 |
Total liabilities and stockholders’ equity | $ 12,793 | $ 12,209 |